Three transcriptionally distinct forms of epstein-barr virus latency in somatic cell hybrids: Cell phenotype dependence of virus promoter usage
- 1 March 1992
- Vol. 187 (1) , 189-201
- https://doi.org/10.1016/0042-6822(92)90307-b
Abstract
No abstract availableKeywords
This publication has 37 references indexed in Scilit:
- Induction of bcl-2 expression by epstein-barr virus latent membrane protein 1 protects infected B cells from programmed cell deathCell, 1991
- Activation of Epstein–Barr virus latent genes protects human B cells from death by apoptosisNature, 1991
- Different Epstein--Barr virus--B cell interactions in phenotypically distinct clones of a Burkitt's lymphoma cell lineJournal of General Virology, 1990
- Expression of Epstein‐Barr virus‐encoded proteins in nasopharyngeal carcinomaInternational Journal of Cancer, 1988
- Downregulation of cell adhesion molecules LFA-3 and ICAM-1 in Epstein-Barr virus-positive Burkitt's lymphoma underlies tumor cell escape from virus-specific T cell surveillance.The Journal of Experimental Medicine, 1988
- Monoclonal and polyclonal antibodies against Epstein-Barr virus nuclear antigen 5 (EBNA-5) detect multiple protein species in Burkitt's lymphoma and lymphoblastoid cell linesJournal of Virology, 1987
- DNA sequence and expression of the B95-8 Epstein—Barr virus genomeNature, 1984
- A human‐human hybridoma system based on a fast‐growing mutant of the ARH‐77 plasma cell leukemia‐derived lineEuropean Journal of Immunology, 1982
- Continuous growth and differentiation of human myeloid leukaemic cells in suspension cultureNature, 1977
- Continuous culture of human lymphoblasts from peripheral blood of a child with acute leukemiaCancer, 1965